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Chapter 1
Ultra-Stable Hemoglobin-Poly(Acrylic Acid) Conjugates

1

1.1 Abstract

Stabilization of proteins against thermal deactivation is a major challenge, and a simple, facile,
novel chemical approach is described here to overcome this hurdle. We report here, for the first
time, the successful synthesis of ultrastable protein nanoparticles consisting of met-hemoglobin
(Hb) conjugated with low molecular weight poly(acrylic acid) (PAA, M w 8,000) to form discrete
nanoparticles. Hb-PAA nanoparticles were not deactivated when subjected to prolonged thermal
treatment such as steam sterilization conditions (122 ˚C, 40 minutes, 17-20 psi), while the
unprotected Hb lost most of its activity, when subjected to the same heating conditions. Several
Hb-PAA derivatives which resist thermal inactivation, in a similar manner, are produced and
characterized. Interestingly, the highest activity retention, after the above thermal treatment, was
~100% of the untreated samples.

This resistance to heat is attributed to the enhanced

thermodynamic stability of the Hb-PAA conjugate and improved re-folding of the denatured
state to the native form, facilitated by PAA conjugation to Hb. This is a unique approach to
stabilize Hb against thermal inactivation, and it is a major breakthrough in the production of
stable Hb-based nanomaterials that can be safely sterilized in an autoclave for biomedical/in vivo
applications.

2

1.2 Introduction

Improving protein thermal stability is a fundamental problem that is being intensely
investigated,1,2 and steam sterilization conditions provide a bench-mark to evaluate the success
of the strategies used for protein stabilization. Steam sterilization of proteins causes extensive
loss of their biological activity. This is a serious drawback for applications that require
sterilization, 3,4,5 and protein stabilization against steam sterilization has been an elusive goal, so
far. However, it is imperative to improve proteins’ resistance to steam sterilization since this
technique is more commonly available in most laboratories for sterilization using an ordinary
autoclave, effective, and inexpensive to perform. Even the highly stable thermophilic proteins
are deactivated by steam sterilization and proteins designed by rational approaches are
promising, but so far they met with only limited success in this regard.6 Enhanced thermal
stability is also important for improved storage stability of proteins under different
environmental temperatures as well as for biocatalytic applications at high temperatures where
the reactions can be further accelerated. To date, there have been no established theoretical or
experimental approaches to stabilize proteins against steam sterilization and this important goal
of protein thermal stability needs to be achieved.7,8
Protein-polymer nanosystems that are not deactivated by extreme heat, provide unique
avenues to mass-produce thermally stable, steam-sterilizable biomaterials and products.9,10
Suitably designed protein-polymer nanosystems can address this important issue by exploiting
and synergistically combining favorable materials aspects of polymers such as their high thermal
stability with the desired biological activities of proteins.11

The attachment of strongly

hydrophilic polymers such as polyethylene glycol (PEG) to proteins are suggested to stabilize

3

proteins against denaturation or loss of its three dimensional structure, but only limited progress
has been made in terms of improved thermal stability,12,13,14,

15,16

but none of these examples

demonstrated resistance to deactivation against thermal treatments such as steam sterilization.
Several conjugates showed significant retention of activity and improved storage stability but
these also did not indicate resistance against steam sterilization or high temperature biocatalytic
activities.17,18 Although constructing a nanoporous wall around the protein was expected to
improve protein stability,19 resistance of the nanoconjugate to heat denaturation has not been
evaluated. There are no known examples of general methodologies to stabilize proteins against
steam sterilization via conjugation with polymers or otherwise, and overcoming this major
hurdle could have a significant impact on a variety of applications of proteins as biomaterials,
especially those that require sterilization, high temperature performance or long term stability.
Here, we constructed novel protein-polymer nanoparicles and tested them for their thermal
stability against steam sterilization conditions, as a bench mark to evaluate their thermal stability.

4

Scheme 1.1. (Top) Irreversible denaturation, conversion of the native state of the protein (N) to
the corresponding denatured state (D), at the thermal denaturation temperature (Td). (Bottom)
Resistance to thermal deactivation can be achieved by stabilizing the native state with a suitable
polymer (red lines) and/or by facilitating the denatured state to re-fold to the native state
(reversible denaturation).

5

Our hypothesis is that stability can be improved by wrapping the protein in a soft,
hydrophilic, water-soluble, flexible, polyelectrolyte where the hydrophilic polymer chains
improve thermal stability of the protein. Improvement in stability can be due to two factors, 1)
decrease in the conformational entropy of the native state (N) of the protein due to its
encapsulation in the polymer matrix, thereby increasing intrinsic thermal stability of the protein;
and 2) enhanced solubility of the denatured state (D) due to the covalently-bound hydrophilic
polymer chains, which can inhibit aggregation of the denatured peptide and facilitate refolding
back to the native state. Therefore, even if the protein undergoes thermal denaturation under
steam sterilization conditions (122 ˚C, 40 min, 17-20 psi), in principle, it could re-fold into the
native conformation and regain its biological activity, Scheme 1. This hypothesis has been tested
in the current studies.
We successfully show that covalent linking of the carboxyl functions of a water-soluble
anionic polymer to a model protein (Scheme 2) resulted in protein-polymer conjugates that resist
deactivation by steam sterilization conditions.

6

Scheme 1.2. The design of protein-polymer nanoparticles by covalent linking of the amino
groups of hemoglobin (Hb) with the carboxyl functions of low molecular weight poly(acrylic
acid) (PAA, MW 8000). Crosslinking of the polymer layer with ethylenediamine (en),
triethylenetetrammine (teta) or tetraethylenpentamine (tepa) to further stiffen the polymer
chains, and enhance resistance to thermal deactivation under steam sterilization conditions.
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We have chosen poly(acrylic acid) (PAA) as the water-soluble, flexible, anionic polymer
and methemoglobin (Hb) 20,21 as a model protein with multiple amino groups to test the above
strategy. Improving Hb stability to steriliztion is important because it has the potential to be used
as a biocompatible artificial blood substitute or as a biocatalyst with improved thermal stability.
Hb has been linked to PEG, or entrapped in liposomes and vesicles to improve its stability and
potential as a blood substitute.22,23 Use of Hb as an artificial blood substitute, however, would
require retention of its biofunction after sterilization and long term storage stability.24
Previously, we have shown that random crosslinking of a high molecular weight PAA
(MW 450,000) with Hb results in soluble, Hb-PAA nanogels.17

Careful and systematic

evaluation of the nanogels showed that Hb encased in the polymer matrix retained its biological
structure and activities, and that the crosslinking has been benign. However, the nanogels did
not indicate considerable improvement in thermal stability or protection against steam
sterilization.
In sharp contrast, the data presented here shows that protein stability can be increased
substantially by attaching, low molecular weight PAA to Hb to form discrete Hb-PAA
nanoparticles, as opposed to nanogels, via a general, simple, efficient and facile synthetic
strategy (Scheme 2).

The resulting Hb-PAA nanoparticles resist deactivation by steam

sterilization. This simple strategy may be extended to other protein-PAA conjugates and
attaining such thermal stability is a major breakthrough for the biomedical/biomaterial
applications that require sterilization or long term stability.25,26
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1.3 Experimental
1.3.1 Chemicals and Materials
Bovine met-hemoglobin (Hb) was purchased from MP Biomedicals (Solon, OH). Protein
solutions were prepared in the respective buffers used for synthesis, as indicated, and the
concentrations determined from the Soret absorbance of Hb using extinction co-efficient 303,956
M-1cm-1 at 407 nm.27

1.3.2 Polyamines
Ethylenediamine (en), triethylenetetramine (teta), and tetraethylenepentamine (tepa) were
purchased from Sigma (St. Louis, MO). Stock solutions of the polyamines were prepared in
deionized water (DI) and the pH was adjusted to 7.2 with concentrated hydrochloric acid before
the solutions were made to their final volumes.

1.3.3 Protein-Polymer Conjugate Synthesis
The Hb-PAA conjugates were synthesized by using 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDC), purchased from TCI America (Portland, OR), as the coupling agent by
reported methods,28 with minor modifications. PAA (MW 8,000) solution 45% (w/w) was
purchased from Sigma-Aldrich (St. Louis, MO) and diluted four-fold to a concentration of 18.6
mM by the addition of DI. A mixture of 500 μL of 200 mM Na2HPO4 buffer at pH 6, 7 or 8 with
270 μL of PAA (1 mM) and 3730 μL of deionized water were added to a reaction vial, followed
by sonication for 5 minutes. Next, 100 mmol of EDC was added to the vial while stirring. The
resulting PAA/EDC mixture was stirred for 5 minutes and then 500 µl of 10 µM Hb (50 nmol)
was added and stirred for 12 h. Specific reaction conditions for each of all the samples are

9

summarized in tables 1 & 2. Excess EDC, PAA and urea by-product were dialyzed 3 times with
1000 times the sample volume with 25 kDa molecular weight cut off dialysis membrane to
obtain pure protein-polymer conjugates.
The product obtained from the reaction of 5000 nmol of PAA with Hb (50 nmol) at pH 7 (PAA to
Hb mole ratio of 100:1) is designated as Hb-PAA(100)-7, while the reaction of 50,000 nmol PAA with 50
nmol of Hb (PAA to Hb mole ratio of 1000:1) at pH 7 is labeled as Hb-PAA(1000)-7. This nomenclature
will be used throughout the manuscript for unique identification of specific Hb-PAA nanoparticle
samples. Each sample has been centrifuged at 12,000 RPM and filtered using 0.22 µm filter to remove
invisible precipitates, if any.
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Table 1.1. Optimized Reaction Conditions for the synthesis of Hb-PAA(100)-6/7/8 and HbPAA(1000)-6/7/8 from Hb (10 μM, 500 μL, 50 nmol), PAA ( 270/2700 µL, 1 or 10 mM, 5 or 50
µmol, 1:100 or 1:1000 Hb to PAA mole ratio) and EDC (100 mM, 95.8 mg, 500 μmol) in
sodium dibasic phosphate buffer.
Sample
Hb-PAA(100)-6
Hb-PAA(100)-7
Hb-PAA(100)-8
Hb-PAA(1000)-6
Hb-PAA(1000)-7
Hb-PAA(1000)-8

[PAA]
(mM)
1
1
1
10
10
10

PAA Vol
(μL)
270
270
270
2700
2700
2700
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Moles
PAA
5 μmol
5 μmol
5 μmol
50 μmol
50 μmol
50 μmol

Buffer
pH
6
7
8
6
7
8

Buffer
Vol (μL)
500
500
500
500
500
500

DI Vol
(μL)
3730
3730
3730
1300
1300
1300

Table 1.2. Optimized Reaction Conditions for Synthesis of Polyamine Cross-linked
Bioconjugates from Hb-PAA(1000)-8 (5 μM, 2500 μL, 25 nmol), polyamine (en [2 M], teta [1
M] or tepa [1 M]) and EDC (100 mM, 95.8 mg, 500 μmol) in 20 mM Na2HPO4, pH 8
Sample
Hb-PAA(1000)-8-5en
Hb-PAA(1000)-8-10en
Hb-PAA(1000)-8-20en
Hb-PAA(1000)-8-40en
Hb-PAA(1000)-8-60en
Hb-PAA(1000)-8-5teta
Hb-PAA(1000)-8-10teta
Hb-PAA(1000)-8-20teta
Hb-PAA(1000)-8-40teta
Hb-PAA(1000)-8-60teta
Hb-PAA(1000)-8-5tepa
Hb-PAA(1000)-8-10tepa
Hb-PAA(1000)-8-20tepa
Hb-PAA(1000)-8-40tepa
Hb-PAA(1000)-8-60tepa

[en]
(mM)
5
10
20
40
60
-

Moles en

[teta]
(mM)
25 μmol
50 μmol
100 μmol
200 μmol
300 μmol
5
10
20
40
60
-
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Moles
teta
25 μmol
50 μmol
100 μmol
200 μmol
300 μmol
-

[tepa]
(mM)
5
10
20
40
60

Moles
tepa
25 μmol
50 μmol
100 μmol
200 μmol
300 μmol

1.3.4 Protein-Polymer Cross-Linking with Polyamines

Polyamines were used to crosslink the PAA chains of the above Hb-PAA nanoparticles,
using EDC coupling chemistry. To Hb-PAA(1000)-8 in 20 mM Na2HPO4 buffer at pH 8 (5 µM
protein, 5 mL) was added 100 mmol of EDC and the mixture stirred for another 5 minutes before
various volumes of polyamines have been added to gain the desired concentrations of polyamine
(en, teta, and tepa, reaction conditions for other samples given in the ESI, Table S2). The
reaction mixture was further allowed to stir overnight, at room temperature. Excess EDC, PAA
and urea byproduct were removed via dialysis with 25 kDa molecular weight cut off dialysis
membrane.

1.3.5 Agarose Gel Electrophoresis
Native agarose gels were prepared by dissolving molecular biology grade agarose (0.5%
w/v) (U.S. Biological, Swampscott, MA) in a hot solution of Tris-Acetate (40 mM, pH 7.2).29
The gel was run in a horizontal gel electrophoresis apparatus (Gibco model 200, Life
Technologies Inc, MD) using Tris-Acetate (40 mM pH 7.2) as the running buffer. Samples were
loaded into the gel with loading buffer (50 % v/v glycerol and 0.01% m/m bromophenol blue)
and electrophoresis carried out for 30 minutes at 100 V at room temperature. The gel was stained
overnight with 10% v/v acetic acid, 0.02% m/m Coomassie blue and then destained with 10%
v/v acetic acid for an additional night. Polyamine cross-linked protein-polymer nanoparticles
were stained by Zn(II) reverse staining procedure.30 The gel was incubated for 25 minutes in
ZnSO4-Imidazole solution (15 mM ZnSO4:30 mM Imidazole) followed by incubation in a 10%
(w/v) Na2CO3 solution to develop the bands. The gel was photographed using a Molecular
Imager Gel Doc XRS System.
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1.3.6 Transmission Electron Microscopy
Transmission electron microscopy (TEM) was used to examine the morphology of HbPAA conjugate, Hb and PAA physical mixture (Hb/PAA), Hb and PAA. The images were
obtained with a Tecnai T12 instrument operating at an accelerating voltage of 120 kV. Solutions
of Hb-PAA, Hb/PAA and PAA were diluted to 0.1 mg/ml based on PAA concentration. The Hb
solution was diluted to 0.1 mg/ml Hb. A drop of each solution was deposited on a copper grid
covered with Fomvar film. Excess solution was blotted away with a piece of filter paper to leave
a thin layer of solution on the grid. The sample was left to dry in air, and then stained with
ruthenium tetroxide for 30 minutes. Digital images were collected and presented.

1.3.7 Dynamic Light Scattering
Nanoparticle sizes were determined by Precision Detectors (Varian Inc., Santa Clara,
CA) CoolBatch+ dynamic light scattering (DLS) apparatus using a 5 x 5 mm square cuvette, 658
nm excitation laser source with a 90° geometry for the excitation and monitoring optics.
Samples were routinely filtered with a 0.2-micron filter prior to analysis to remove dust particles
and any large aggregates.

1.3.8 Spectral Measurements
The absorption spectra were recorded on HP 8453 spectrophotometer (Agilent
Technologies, Santa Clara, CA).

The Hb solutions mixed in the respective buffers was

determined from the Soret absorbance of Hb using an extinction coefficient of 303,956 M-1cm-1
at 407 nm.

Further, the denaturation temperatures of Hb, Hb/PAA and Hb-PAA were
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determined by measuring the thermal transition points from the plots of Soret absorbance at 407
nm as a function of temperature.

1.3.9 Circular Dichroism
A JASCO model J715 spectropolarimeter (Jasco Inc, Easton, MD) was used to record the
circular dichroism (CD) spectra. Scan rates were 50 nm/min with a step resolution of 1 nm/data
point. Several scans (8-16) were averaged for each sample (0.05 and 1 cm path length) and data
plotted using Kaleidagraph 4.1.1. Samples for CD were prepared as mentioned above and signals
have been normalized with respect to concentrations of individual samples and the pathlength.

1.3.10 Enzymatic Activity Assays
The peroxidase-like activity of Hb was measured by following the literature method, as
reported earlier.31 Product absorbance at 470 nm was monitored as a function time of after the
addition of H2O2 (1 mM) to Hb (1 µM) and o-methoxyphenol (2.5 mM). Lineweaver-Burk plots
for the protein-polymer conjugates were constructed by obtaining initial reaction rates at various
substrate concentrations and by plotting inverse initial rate vs inverse substrate concentration.
The corresponding Michaelis-Menten parameters, the Michaelis constant (Km) and the maximum
velocity (Vmax), were extracted from this plot29 as reported earlier.31

All peroxidase-like

activities of steam sterilized samples were measured with 1 µM Hb, 2.5 mM guaiacol and 1 mM
H2O2 in 20 mM Na2HPO4 buffer, pH 7.2, or 8, at room temperature using the above method.

1.3.11 Differential Scanning Calorimetry
15

A Nano II differential scanning calorimeter (DSC) 6100 from Calorimetry Sciences
Corporation (CSC, Utah) was used to perform thermal denaturation experiments.32 The amount
of heat required to increase the temperature of a sample with respect to a reference (Cp) by 1 ºC
was monitored in a series of heating and cooling scans from 20 to 120 ºC at a scan rate of 2
ºC/min. Thermodynamic parameters (∆H, and Tm) were obtained from the DSC traces, as
described earlier.

1.3.12 Steam Sterilization
An Amsco Century Scientific (Steris, Mentor, OH) model SI-120 isothermal sterilizer
was used for steam sterilization. Liquid samples containing Hb-PAA conjugates and unmodified
proteins were steam sterilized for 40 min at 122 ˚C (17-20 psi). Samples were cooled down to
room temperature and the peroxidase-like activity of Hb and Hb-PAA conjugates were
measured, as described above. The initial rates were calculated using Kaleidagraph from the
kinetic traces of absorbance vs time plots, and specific activities have been calculated.
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1.4 Results and Discussion
Hb-PAA covalent conjugates are synthesized by covalent linking of the carboxyl
functions of PAA with the amino groups of the lysine side chains of Hb, under controlled
conditions of stoichiometry, polymer concentration, polymer molecular weight, pH and reaction
time. Previously, we have shown that covalent linking of high molecular weight PAA (MW
450,000) to Hb resulted in the formation of protein-polymer nanogels which did not retain
activity after steam sterilization.17

Here, we lowered the PAA molecular weight and its

concentration to suppress network formation, and increased the mole ratio of polymer to protein
to produce discrete Hb-PAA nanoparticles, which indicated high resistance to thermal
deactivation.

1.4.1 Synthesis of Hb-PAA Nanoparticles
Proteins, in general, are polyfunctional molecules with large numbers of amine and
carboxyl groups on them. The amino groups of the lysine side chans of proteins have been
successfully coupled with a large number of substrates consisting of carboxyl groups, via the
standard carbodiimide chemistry.33 A similar strategy was followed here (Scheme 2). Covalent
attachment of a large excess of PAA (MW 8000, 100 or 1000-fold molar excess) to the lysine
side chains of Hb was carried out by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) at
pH 6, 7 or 8, in 20 mM Na2HPO4 buffer (ESI, Table S1). All the conjugates reported here were
completely soluble at all times, and there have been no precipitates or gel formation. Most
mammalian Hb molecules have ~44 lysine residues, and a large number of them can potentially
react with the activated carboxyl groups of PAA. The Hb/PAA/EDC reaction mixture was
allowed to react for 12 h and dialyzed to remove the unreacted PAA, EDC or urea by-products.
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All samples reported here are completely water-soluble and there have been no precipitates
under our reaction conditions. Progress of the crosslinking reaction was followed by agarose gel
electrophoresis, described below.

1.4.2 Agarose Gel Electrophoresis
The covalent attachment of anionic PAA to Hb is expected to give rise to negatively
charged Hb-PAA conjugates, and this conversion of positively charged Hb to negatively charged
conjugate is expected to increase its electrophoretic mobility toward the positive electrode. In
contrast, if the synthesis resulted in the formation of macroscopic protein-polymer macrogels, the
gels would not migrate through the narrow pores due to their large size, when compared to the
gel pores (~450 nm). As anticipated, the Hb-PAA(100) conjugates (100-fold excess PAA per
Hb, lanes 4-6, Fig. 1) moved towards positive electrode, while Hb, Hb/PAA physical mixture, or
Hb/EDC mixture (lanes 1-3, respectively) migrated towards the negative electrode. Migration
reversal is not due to physical binding of PAA to Hb, as the mixture (lane 2) migrated toward the
negative elecgtrode but not the positive electrode. The presence of a new band in lanes 4-6 and
the absence of the Hb band, indicated complete conversion of Hb to the corresponding Hb-PAA
conjugate. In contrast, the Hb-PAA nanogels produced from the conjugation of high molecular
weight PAA (MW 450,000) with Hb, moved as streaks, under the same conditions of
electrophoresis.17a Thus, the covalent linking of the anionic polymer to Hb to form discrete
particles is clearly demonstrated.
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Positive Electrode

Negative Electrode
Lane 1

2

3

4

5

6

Figure 1.1. Agarose gel of Hb (lane 1), Hb/PAA physical mixture (lane 2), Hb/EDC mixture
(lane 3) and Hb-PAA(100) nanoparticles synthesized at pH 6, 7 and 8 (lanes 4-6, respectively)
spotted at the center of the gel (0.5% agarose, 40 mM Tris acetate, pH 6.5). The Hb, Hb/PAA
physical mixture and Hb/EDC mixture migrated towards the negative electrode, while all the
three Hb-PAA(100) covalent conjugates moved towards the positive electrode. These lanes did
not show any unreacted Hb.
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We also prepared Hb-PAA(1000) samples at pH 6, 7, and 8, where there has been 1000fold molar excess of the polymer, and compared the mobilities of these samples with those of
Hb-PAA(100) samples (Figure 2). While the Hb-PAA(100) samples indicated tight bands (lanes
2-4), the Hb-PAA(1000) samples (lanes 5-7, respectively) had more diffuse bands due to higher
concentrations of PAA. These lanes also did not indicate free Hb (lane 1) and both reaction
conditions resulted in the complete conjugation of Hb with the polymer, and there has been no
visible precipitation under any of the reaction conditions reported here.
Electrophoretic mobilities of all the Hb-PAA conjugates (both 1:100 and 1:1000 mole
ratio samples, prepared under three different pH conditions) indicated a measure of the charge
and size. The average pore size of agarose gel used in Figure 1 & S1 (0.5% gel) is around 450
nm,
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and all the Hb-PAA conjugates moved readily through these pores. Therefore, the

conjugates are likely to be much smaller than 450 nm. Additionally, there is no formation of
macroscopically crosslinked gels, which would have indicated streaks of bands or precipitation
in the wells.17a This conclusion is consistent with the observed high solubility of the conjugates
in the reaction mixture and the low overlap concentration of low molecular weight of PAA (MW
8,000) used in the current studies. The agorose gel data confirm the clean ligation of Hb to PAA
with particle sizes well below 450 nm.35 All conjugates reported here are completely water
soluble and there have been no precipitations under any of these conditions.
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Positive Electrode

Negative Electrode
Lane # 1

2

3

4
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Figure 1.2. Agarose gel of Hb (lane 1), Hb-PAA(100) samples synthesized at pH 6, 7,
and 8 (lanes (104, respectively) and Hb-PAA(1000) samples synthesized pH 6, 7, and 8,
(lanes 5-7, respectively) spotted at the center of the gel (0.5% agarose, 40 mM Tris
acetate, pH 7). Hb, migrated towards the negative electrode, while all the three HbPAA(100) covalent conjugates moved towards the positive electrode. These lanes did
not show any unreacted Hb.
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1.4.3 Elemental Analysis
Covalent conjugation of carbon rich PAA polymer to Hb is expected to increase the C:N
ratio, and from this ratio, one can assess the amount of polymer bound per protein molecule. For
example, the C:N ratio of 6.34 was measured for the Hb-PAA(1000)-8 which increased from
3.51 for the untreated Hb.

Since the nanoparticles were extensively dialyzed to remove

unreacted PAA, the increase in C:N ratio is indicative of increase in carbon content (PAA) of the
conjugate. From this ratio we deduce that on average nearly 7 PAA polymer chains were
attached for every Hb in Hb-PAA(1000)-8, giving a Hb:PAA stoichiometry of 1:7. Since
molecular weight of PAA is 8000, that of Hb is 64,500, and seven of these chains are attached to
one Hb molecule, the average mass ratio of protein to polymer is nearly (64,500):(7x8,000) or
~1:0.9, or approximately equimass ratio. Thus, each protein molecule is surrounded by several
low molecular weight polymer chains, and even at 1000-fold higher concentration of PAA only a
few chains are attached to the protein.

1.4.4 TEM and DLS
The Hb-PAA samples were visualized by TEM to determine their morphology, size,
shape and phase separation characteristics. In general, TEM micrographs indicated spherical
particles and we did not see macrogels or highly crosslinked products (Figure 2). Hb-PAA(100)
synthesized at pH 7, for example, (Figure 2b) indicated spherical spots with a dark core and very
light corona (inset).
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Figure 1.3. TEM images of Hb-PAA(100) and Hb-PAA(1000) samples synthesized at pH 6, 7
or 8 after ruthenium oxide staining: a) Hb-PAA(100)-6, b) Hb-PAA(100)-7, c) Hb-PAA(100)-8,
d) Hb-PAA(1000)-6, e) Hb-PAA(1000)-7 and f) Hb-PAA(1000)-8. In some micrographs, the
dark spots at the centers (insets) are clearly surrounded by a very light corona.
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The TEMs of the Hb-PAA(100) samples synthesized at 6, 7 and 8, are compared in
Figure 2(a-c) and none of these indicated nanogels or macroscopically crosslinked gels. The
insets in these panels are expanded views of randomly chosen particles to illustrate their contours
better, and the average sizes of the Hb-PAA(100) particles synthesized at pHs 6, 7, and 8 were
~250, ~125 and ~100 nm (Figure 2a-c), respectively. The particle size decreased, percptibly,
with increase in pH, at Hb:PAA concentration ratio of 1:100. This decrease in size could be due
to increased charge repulsion between the PAA and Hb chains, as the pH is increased and fewer
molecules are attached at higher pH.
Next, we examined the influence of PAA concentration on the particle formation and the
TEM micrographs of Hb-PAA(1000) samples prepared with a protein to polymer ratio of 1:1000
also indicated nanoparticles (Figure 2e). These are also nearly spherical, with a dark core and a
very light corona, in some cases, and they also did not indicate the formation of any macroscopic
gels. These are compared with those synthesized at pH 6 and 8 (Figure 2d-f) which also showed
spherical nanoscopic species, and none of them indicated nano- or macrogels. The HbPAA(1000) samples synthesized at pH 6, 7, and 8 had average sizes ~80, ~90 and ~100 nm,
respectively, and these are smaller than those obtained at lower stoichiometries of Hb to PAA.
Higher polymer concentration (higher stochiometry) decreased the particle size, and this could
be due to the greater distribution of Hb molecules among a larger number of PAA chains,
resulting in smaller particle formation.
The sizes of the 1000:1 samples increased slightly with increase in pH which is opposite
to what was noted with the 100:1 samples, where the size decreased with increase in pH. Thus,
not only the pH but also the polymer concentration influenced the particle size to a measurable
extent, while the shape and morphology appears to be nearly independent of these factors.
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Lower pH and higher PAA concentration resulted in the smallest particles. Thus, the particle
size can be tuned from about 250 nm to around 80 nm, in a predictable manner, depending on the
reaction conditions.
The formation and size of the Hb-PAA nanoparticles determined from TEM are also
corroborated by dynamic light scattering (DLS) data (Figure 3), where the trends in size with pH
and polymer concentration are similar to those obtained from TEM micrographs. The conjugates
synthesized at pH 6.0 show major distribution, around 150 nm, while the conjugates synthesized
at pH 7.0 and 8.0 show the major size distribution around 145 and 114 nm, respectively.
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Figure 1.4. Dynamic light scattering plots for Hb-PAA(100) and Hb-PAA(1000) conjugates
synthesized at pH 6, 7 and 8, respectively. The conjugates synthesized at pH 6.0 show major
distribution, around 150 nm, while the conjugates synthesized at pH 7.0 and 8.0 show the major
size distribution around 145 and 114 nm, respectively. All samples were in 20 mM Na2HPO4
buffer.
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1.4.5 Hemoglobin Structure in Hb-PAA Conjugates
Native structure of the encapsulted protein is critical for the retention of its biological
activity, and we used circular dichroism (CD) spectroscopy to assess Hb structure before and
after conjugation to PAA. The CD spectra of the Hb-PAA nanoparticles in the far-UV region
(Figure 4a) are similar to that of Hb,36 and these indicated significant retention of its native-like
secondary structure upon conjugation with PAA. These peak positions, intensities and ratio of
the intensities of 222/209 nm peaks are compared in Table 1. In conclusion, the UV CD data
confirm that the protein secondary structure is not adversely effected by the conjugation reaction.
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b

Figure 1.5. (a) Far UV CD of Hb, and Hb-PAA(100) conjugates synthesized at pH 6 (red),
7 (green) and 8 (blue) when compared to that of Hb (black); (b) Soret CD of the HbPAA(100) samples with the same color code, as the left panel. All spectra were normalized
to obtain molar rotation per unit path length.
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The Soret absorption band of Hb also gives rise to the corresponding CD and it is a
sensitive signature of the structural changes at the heme binding pocket. Soret CD served as
another means to interrogate the influence of conjugation on protein structure. The Soret CD of
the Hb-PAA(100) samples synthesized at pH 6, 7 and 8 are compared with that of Hb (Figure
4b), and these indicated some loss in intensity after conjugation, but the peak positions of the
nanoparticles matched with that of Hb. The Soret CD spectra suggest that the heme binding
pocket has undergone some distortion, even though the secondary structure of Hb remained
mostly intact. These CD data are summarized in Table 3, for convenience, and these clearly
show significant retention of the secondary structure, but the loss in Soret intensity of some
derivatives was of concern, and hence, we tested if these changes adversely influenced the
peroxidase-like activity of Hb-PAA nanoparticles, as discussed below.
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Table 1.3. Far UV and Soret CD intensities (mdeg/µM.cm) of Hb-PAA(100) conjugates

Hb
Hb/PAA
Hb-PAA(100)-6
Hb-PAA(100)-7
Hb-PAA(100)-8

222 nm
-80
-92
-93
-91
-86

209 nm
-74
-89
-88
-88
-91
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222/209 nm
1. 07
1. 03
1. 06
1. 03
1. 00

409 nm
2. 17
2. 05
1. 13
1. 93
1. 56

1.4.6 Peroxidase-like Enzymatic Activities of Hb-PAA
Hb does not function as an enzyme in biological systems but its peroxidase-like activity
has long been known.37,38 Catalytic activity of Hb-PAA nanoparticles was monitored by the
reaction of guaiacol (substrate) with hydrogen peroxide (oxidant), and formation of the colored
product has been monitored by its absorption at 470 nm, as a function of time (Figure 4). For
example, the product formation catalyzed by Hb-PAA(100)-6 (Figure 4a, green curve) is nearly
comparable to that of Hb (black curve), there has been no reaction in the absence of hydrogen
peroxide (red curve), and PAA did not catalyze the reaction (data not shown). A mixture of Hb
and PAA (black dashed curve) indicated activites that are lower than that of the corresponding
Hb-PAA conjugate.
Similarly, the peroxidase activity of Hb-PAA(1000)-7 is shown in Supplementary
Materials S4, and the activities are comparable to that of Hb or the physical mixture of Hb/PAA.
These data are consistent with the conclusion that PAA did not adversely influence peroxidase
activity of Hb-PAA nanoparticles.
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a

b

c
Figure 1.6. (a) The peroxidase-like activities of Hb-PAA(100)-6 (green curve), Hb, (black
curve) and mixture of Hb and PAA (black dotted curve), and in the absence of hydrogen
peroxide (red curve) (1 µM protein, 2.5 mM guaiacol and 1 mM H2O2 in 20 mM Na2HPO4
buffer, pH 7.2). (b) The peroxidase-like activities of Hb-PAA(1000)-7 (green curve), Hb, (black
curve) and mixture of Hb and PAA (black dotted curve), and in the absence of hydrogen
peroxide (red curve) (1 µM protein, 2.5 mM guaiacol and 1 mM H2O2 in 20 mM Na2HPO4
buffer, pH 7.2). (c) Comparison of the specific activities of Hb-PAA nanoparticles with that of
Hb and physical mixtures, all measured at room temperature, 1 µM protein, 2.5 mM guaiacol and
1 mM H2O2 in 20 mM Na2HPO4 buffer, pH 7.2.
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The initial rates from the kinetic traces of all the six Hb-PAA nanoparticle samples were
measured and compared with those of Hb and Hb/PAA physical mixtures (Figure 5c). The
conjugates showed significant activity, and only in the case of Hb-PAA(100)-8, substantial
reduction has been noted (~40% loss), the remaining five samples had specific activities close to
that of Hb (Table 5). Some improvements may have been noted in some cases but these are well
within the experimental errors indicated. While the Hb/PAA(100) physical mixture was nearly
as active as Hb, the Hb/PAA(1000) physical mixture was measurably less active and this could
be due to increased viscosity of the solution due to the higher PAA concentration in the mixture.
The majority of Hb-PAA nanoparticles, however, retained most of their peroxidase-like
activities.
Initial reaction rates from the kinetic data were obtained at a series of substrate
concentrations and they have been used to construct Michaelis-Menton plots for the extraction
of the corresponding enzymatic parameters, Michaelis constant (Km) and the maximum velocity
(Vmax).29 The plot of inverse of the initial rate as a function of the inverse of the substrate
concentration indicated linear plots for Hb-PAA(100)-6 and Hb-PAA(100)-7 (Figure 6).
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Figure 1.7. Lineweaver-Burk plots for the peroxidase-like activities of Hb-PAA(100)-6
(black dots), Hb-PAA(100)-7 (red dots). Lines are best fits to the data using the LineweaverBurk equation. All reactions were carried out in the presence of 1 µM Hb-PAA(100)-6 or
Hb-PAA(100)-7, increasing guaiacol concentration and 1 mM H2O2 in 20 mM Na2HPO4
buffer, pH 7.2, room temperature.
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Table 1.4. Specific activities (x10-3 µM/mg) of Hb-PAA nanoparticles measured at 25 ˚C, 20
mM phosphate buffer, pH 7.2.

Sample

Specific activity (x10-3 µM/mg)

Hb

2. 5  0.3

Hb/PAA(100)

2. 3  0.07

Hb-PAA(100)- 6

2. 4  0.5

Hb-PAA(100)- 7

2. 0  0.2

Hb-PAA(100)- 8

1. 4  0.07

Hb/PAA(1000)

2. 0  0.07

Hb-PAA(1000)- 6

2. 7  0.4

Hb-PAA(1000)- 7

2. 6  0.07

Hb-PAA(1000)- 8

2. 4  0.1
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Linear fits to these data (Figure 6) using the Michaelis-Menton model indicated Vmax of
0.0028, 0.0025 and 0.0026 mM/s and Km of 1.25, 0.375 and 0.50 mM, for Hb-PAA(100)-6, HbPAA(100)-7 and Hb,39 respectively. under similar conditions of buffer, ionic strength,
temperature and pH. The maximum velocities observed with all the three samples, for example,
are similar, and polymer conjugation did not alter this parameter to a significant extent. While
the Km of Hb-PAA(100)-6 is three times larger than that of Hb, the Km of Hb-PAA(100)-7
matched well with that of Hb. Enhanced Km of Hb-PAA(100)-6 is indicative of a decrease in its
affinity for the substrate, and this observation is intriguing but it also coincides with the
substantial loss of its Soret CD band. Therefore, in this case, the heme-pocket in the globin is
distorted enough to cause substantial reduction of the binding of the substrate at the active site
but not its catalytic efficiency.

Overall, the catalytic parameters found for Hb-PAA

nanoparticles are consistent with the notion that formation of the covalently conjugated
nanoparticles did not substantially alter Hb native-like structure or its peroxidase-like activities.
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1.4.7 Melt Curves and DSC Studies
Encouraged by the retention of secondary structure and biocatalytic activities of the HbPAA nanoparticles, we next assessed their thermal stability by recording Soret absorbance as a
function of temperature (melt curves) as well as by differential scanning calorimetry (DSC).
While the melt curves provide a quick measure of thermal stability, reversibility and precipittion
of the sample during or after denaturation, the DSC40 provides a direct quantitative measure of
the thermodynamic parameters of thermal denaturation.41
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Figure 1.8. (a) Melt curves of Hb, Hb/PAA physical mixture, and Hb-PAA(100)-7 recorded by
monitoring heme absorption at 410 nm as a function of temperature. Improved stability of the
conjugate is indicated by the shift of its melt curve to higher temperatures; (b) DSC thermograms
(molar heat capacity plots) of Hb-PAA(100)-7 (green curve), Hb (black curve), and the Hb/PAA
physical mixture (dotted line) as a function of temperature.
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On one hand, a plot of the ratio of the Soret absorbance of the sample at 407 nm (A) to
initial absorbance of the sample (Ao) as a function of temperature (Figure 7a), indicated a sharp
increase flollowed by decrease with a peak around 65 ˚C for Hb (black curve), and this is
consistent with the denaturation of Hb followed by its precipitation from solution, around this
temperature.42 On the other hand, the melt curve for Hb-PAA(100)-7 (Figure 7a, green line),
under the same conditions of buffer, pH and ionic strength, indicated the beginning of a change
around 60 ˚C, which continued upto 100 ˚C but no precipitation has been noted. The physical
mixture of Hb and PAA (black dotted line) indicated some stabilization followed by denaturation
but eventually precipitated. Thus, Hb-PAA(100)-7 indicated improved thermal stability when
compared to that of Hb or the corresponding Hb/PAA physical mixture.

The melt curves of

other Hb-PAA conjugates also indicated improved stability when compared to that of Hb, no
precipitation, and the Soret absorption band recovered upon cooling the samples to room
temperature. These details are discussed latter.

39

Table 1.5. Thermodynamic parameters for the denaturation of Hb-PAA nanoparticles
Hb

Hb/PAA Hb-PAA(100)-6

Hb-PAA(100)-7

Hb-PAA(100)-8

Td/˚C

68±0.2

68±0.5

61±3.0

77±3.0

65±1.2

∆H/kcal/mol

135±5

145±10

310±40

540±35

130±20
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To quantify the thermodynamic parameters of protein denaturation, the DSC curves of
Hb-PAA(100)-7, Hb and Hb/PAA physical mixture were recorded and the denaturation
temperatures (Td) have been determined (Figure 6b). The DSC profile of Hb-PAA(100)-7 (green
curve), for example, indicated a small peak around 77 ˚C, and then a much larger transition near
100 ˚C. The first, smaller peak is slightly shifted to higher temperature when compared to that of
Hb (black curve, Td of 68 ˚C).42 The DSC profile of the Hb/PAA physical mixture (balck dotted
curve) indicated an endothermic transition larger than that of Hb, with a T d of 63 ˚C, below that
of Hb. PAA itself (thin black line) did not indicate any detectable transition in this temperature
range, and hence, the nanoparticles indicated much greater stability (two separate transitions)
when compared to that of Hb or the correspnding physical mixture. Such high thermal stability is
unusual for most proteins.43
The denaturation enthalpies (∆H) were estimated from the DSC curves, and these are
compared in Table 2. The ∆H for the denaturation of the nanoparticles ranged from 130 to 540
kcal/mol, and enthalpy changes of Hb-PAA(100)-6 and Hb-PAA(100)-7 are significantly higher
than those of Hb (135 kcal/mol) as well as Hb/PAA physical mixture (145 kcal/mol). HbPAA(100)-8 had denaturation enthalpy and peak transition temperatures similar to that of Hb.
The improved thermal stability of Hb-PAA(100)-7 (Td shifted to higher temperature, another
transition at higher temperature as well as higher enthalpy of denaturation) is clearly
demonstrated. Thus, the thermal stabilities are either comparable to that of Hb or higher, and
hence, we decided to examine the extent of reversibility of the thermal denaturation of the HbPAA conjugates. If the denaturation is fairly reversible, then the nanoparticles are of high
promise for steam sterilization studies, and we used steam sterilization as a benchmark of
thermal stability.
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1.4.8 Reversibility of Thermal Denaturation
To test the reversibility of the thermal denaturation of the Hb-PAA nanoparticles, these
were heated to 90 ˚C followed by cooling to room temperature for 15 minutes, and the CD
spectra of the samples have been recorded before and after heat treatment. A comparison of the
CD spectra of Hb-PAA(100)-7 before and after 90 ˚C treatment are compared to those of the Hb
treated in a similar manner (Figure 7). The Hb-PAA(100)-7 sample, which showed the best
thermal stability among the three samples described in the DSC studies, indicated extensive
retention of UV CD after the 90 ˚C heat treatment (Figure 8), The CD spectrum of the sample
after heating (red dotted curve) indicated the same minima and maxima peak positions as that of
the sample before heating (red curve). However, small decreases in the intensities of the heat
treated sample is clearly evident, and these suggest that the thermal denaturaiton is mostly
reversible, but not 100%.
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Figure 1.9. Far UV CD of Hb-PAA(100)-7 (red thick line) and Hb (black thin line) before
heating is compared with the corresponding spectra obtained after heating the samples to 90
˚C for 15 minutes, followed by cooling to room temperature for 15 min (red dashed, and
black dashed lines, respectively).
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In contrast, the CD spectra of Hb before (black solid curve) and after 90 ˚C heat
treatment (black dashed curve) show that the peak intensities decreased substantially, and its
thermal denaturation is essentially irreversible, under the same conditions of pH, buffer and ionic
strength. Near-complete reversibility of thermal denaturation of the Hb-PAA(100)-7, however,
is clearly demonstrated above, and the soft, hydrophilic polymer might facilitate refolding, upon
cooling to room temperature. Improved resistance to heat deactivation and facilitated recovery
of the native-like structure after heating, are in support of the initial hypothesis, and next, we
examined the resistance to steam sterilziation as a bench mark of protein thermal stability.

1.4.9 Stability towards steam sterilization
Improved resistance of Hb-PAA(100)-7 toward heat and near-complete reversibility of
denaturation indicated that the Hb-PAA nanoparticles are potentially promising candidates to test their
ability to resist deactivation by steam sterilization. We examined the peroxidase-like activities of HbPAA samples after they have been subjected to steam sterilization conditions (122 ˚C, 40 minutes, 17-20
psi) and cooled back to room temperature. If the samples retained their activities after steam
sterilization, it would be a major breakthrough in improving Hb stability.

44

a

b

Figure 1.10. Effect of steam sterilization (122 ˚C, 40 minutes, 17-20 psi) on the relative
activities of: (a) Hb-PAA nanoparticles compared with those of Hb, Hb/PAA physical
mixtures which are also treated similarly, and (b) polyamine crosslinked Hb-PAA(1000)-8
nanoparticles compared with that of Hb, before and after steam sterilization. All
measurements were in phosphate buffer, pH 7.2, at room temperature.
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The peroxidase-like activities of the steam sterilized samples are measured at room
temperature, and the extent of recovery of activity or the ratio of the initial rate before heating to
initial rate after heating of each sample is shown in Figue 9a. If the activity is not affected by
heating, this ratio will be 1, while the actual value shows the per cent activity retention, so that
all samples can be compared with a single measure.
Essentially all Hb-PAA(100) samples, retained their activities by 75-85% and this is
remarkable. Hb-PAA(100)-6, for example, retained nearly 80% of its activity after steam
sterilization. In contrast, Hb lost almost 80% of its activity after sterilization, retained only
~20% of its original activity, and the Hb-PAA(100) nanoparticles showed extensive resistance to
deactivation by steam sterilization.

Hb-PAA(1000)-7 and Hb-PAA(1000)-8 also retained

appreciable activities, but much less than their Hb-PAA(100) counterparts. Extensive activity
retention is a surprise, as the Hb-PAA nanogels prepared from high molecular weight PAA
(450,000) did not retain their activities after steam sterilization.17 Thus, the polymer molecular
weight played a major role in the resistance to thermal deactivation. Note that Hb/PAA physical
mixtures also resisted thermal deactivation to a substantial extent and this clearly shows the role
of the polymer in assisting the refolding of the denatured Hb or the prevention of the aggregation
of denatured Hb molecules. The advantage of the covalent linking approach of the current HbPAA nanoparticles is that these samples are discrete and they will not be subjected to leaching of
the polymer from the protein or when diluted for practical applications.

1.4.10 Effect of Cross-Linking with Polyamines
Since Hb-PAA(1000)-8 retained only about half of its activity, we decided to examine if
crosslinking of the COOH groups of the PAA chains with polyamines would improve their
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resistance to thermal deactivation. The crosslinking could stiffen the polymer chain and might
enhance protein stability or improve the reversibility of denaturation. The Hb-PAA(1000)-8
samples, accordingly, were crosslinked with polyamines, en, teta or tepa using EDC chemistry
(Scheme 2), purified by dialysis, and their purity confirmed by agarose gel electrophoressis
(Figure 10). Due to the high PAA content of these samples, their bands do not stain properly
with Coomassie Blue, and we used Zn(II)-imidazole reverse staining to locate the bands in the
gel. These amine-crosslinked samples also indicated discrete, negatively charged bands where
the extent of negative charge inversely varied with the extent of amine-adduction. All samples
were completely soluble under these conditions, and no precipitation or macroscopic networks
are formed. Reaction with the polydentate amines reduced the net charge on the particles, as seen
in the agarose gels, but the reaction conditions were adjusted such that amines did not crosslink
different particles, that is intraparticle crosslinking is achieved over interparticle crosslinking.
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Figure 1.11. Agarose gel (0.5%) of Hb (lane 1), Hb-PAA(1000) (lane 2), and Hb-PAA(1000)teta (lanes 3-6) synthesized in phosphate buffer, pH 8. The samples were spotted at the bottom
of the gel (running buffer, 40 mM Tris acetate pH 7.2). While Hb moved as a streak (lane 1,
faint band), Hb-PAA(1000)-8 (lane 2) and Hb-PAA(1000)-teta (lanes 3-6, crosslinked with 60,
40, 20 and 10 mM teta, respectively) showed single bands. Hb-PAA(1000)-teta crosslinked
nanoparticles moved lesser toward the positive electrode than Hb-PAA(1000)-8 due to
neutralization of the negative charge by the reaction with the amine.
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We tested stabilities and reversibility of the thermal denaturation of these amineconjugated Hb-PAA nanoparticles (Figure 11).

Absorbance spectra of Hb-PAA(1000)-8-

polyamine conjugates before heat denaturation at room temperature (blue curve), during
denaturation at 90 ˚C (red curve) and after cooling back to room temperature (green curve), are
recorded and analyzed. For example, the Hb-PAAA(1000)-20teta sample indicated that its Soret
band shifted from 410 to 395 nm on heating to 90 ˚C, and the Soret band shifted back to 410 nm
upon cooling the sample back to room temperature. The blue shift of the Soret band at 90˚C
clearly indicates the denaturation of the protein structure around the heme binding pocket, and its
recovery back to 410 nm upon cooling supports the notion that the protein structure is recovered
substantially. All three corsslinked samples (Hb-PAA(1000)-teta, Hb-PAA(1000)-tepa and HbPAA(1000)-en) indicated similar, reversible thermal denaturation, under these conditions. The
thermal denaturation of the entrapped Hb in the conjugates, is therefore, mostly reversible. This
conclusion is supported by the fact that these samples also recovered their peroxidase-like
activity to a significant extent, after steam sterilization, described earlier. In contrast to the
reversible denaturation of these amine conjugates, Hb underwent near-complete irreversible
thermal denaturation, under the same conditions.
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a

b

c
Figure 1.12 (a-c). Absorbance spectra of Hb-PAA(1000)-8-polyamine conjugates before heat
denaturation at room temperature (blue curve), during denaturation at 90 ˚C (red curve) and after
cooling back to room temperature (green curve), panels as labeled. Thermal denaturation clearly
shifted the Soret band to higher temperatures and upon cooling most of the Soret band intensity
and position are recovered, which suggests a high degree of reversibility of the thermal
denaturation of these samples. In contrast, Hb underwent near complete irreversible thermal
denaturation, under the same conditions.

50

These amine-modified Hb-PAA(1000)-8 samples were then evaluated for the retention of
their peroxidase-like activity after steam sterilization. Percent activities of the samples after
steam sterilization with respect to that of Hb before steam sterilization are shown in Figure 8b as
a bar graph. All the crosslinked samples retained greater activities than Hb, and the activity
retention with respect to Hb-PAA(1000)-8 improved initially, with the concentration of amine
used for crosslinking, and as the amine concentration used for crosslinking increased the
activities after steam sterilization decreased. Some improvement over Hb-PAA(1000)-8 was
noted in several cases and overall, the crosslinking had substantial improvement in thermal
stability or reversibility of the denaturation. In total, we tested 30 distinct samples or mixtures,
and most of them except Hb, indicated substantial retention of activity after steam sterilization.

1.5 Conclusions
Covalent conjugation of suitable polymers with appropriate proteins provides exciting
new opportunities in materials chemistry, but only a limited progress has been made due to the
wide spread use of very few polymers such as PEG carrying a very limited number of functional
groups. Here, we demonstrate a simple, modular approach, where the covalent conjugation of a
water-soluble, multifunctional polymer, PAA, to lysine residues of a generic protein such as Hb
can be controlled to produce Hb-PAA nanoparticles with controlled size, high solubility,
improved thermal stability and near-reversible thermal denaturation.

The conjugates are

endowed with the biological activities of the protein with unique, novel attributes.
Based on the TEM/DLS data, and gel electrophoresis, we suggest that discrete
nanoparticles are formed, and covalent linking allows the co-habitation of the protein and the
polymer phases within the same particles. Surprisingly, the Hb-PAA nanoparticles indicated
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considerable retention of the elegant hierarchical 3D structure of Hb, its peroxidase-like activity
and fairly narrow size distribution for a major population of the particles. TEM data strongly
suggest that the conjugates are primarily made of protein-PAA nanoparticles, not gels. The
physical characteristics of the nanoparticles such as size, structure retention and stability are
influenced by the composition of the conjugate as well as the reaction conditions such as pH and
stoichiometries.
One exciting observation is that all the Hb-PAA nanoparticles tested here, retained their
biological activities after steam sterilization, and this is highly unusual. Most of them retained
substantial activities while Hb lost most of its activity under these conditions. Steam sterilization
has been known to deactivate proteins, and it is a stumbling block in the development of protein
therapeutics and protein-based materials for biomedical applications. Our earlier study on HbPAA conjugates which used higher molecular weight PAA (MW 450,000) did not indicate
resistance to thermal deactivation. Therefore, the current results demonstrate dependence on the
molecular weight of PAA as well as the high mole ratio of the protein to polymer of the
nanoparticles.

Excess PAA reduced the extent of resistance to thermal deactivtion while

crosslinking with polyamines improved the resistance only marginally.

Overall, several

examples of Hb-PAA are shown here, which resist thermal deactivation well and set new
standards for the thermal stabilities of proteins. Our approach may provide new opportunities for
the design of novel protein-polymer conjugates, carefully tailored, for a variety of applications
where sterilized protein-based products are essential.
We speculate that several unique features of these nanoassemblies are responsible for the
observed retention of activity after steam sterilization. One major factor, among them, is that the
polymer assists the solubilization of the denatured protein and the individual nanoparticles are
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kept apart from agglomeration and precipitation by the anionic polymer, so that they refold to the
active form on cooling. Shielding of the protein from the external microenvironment by the
polymer could enhance the intrinsic stability of the protein. There could be a kinetic factor for
the slow denaturation of the protein or partial retention of the structure after denaturation, and
when these factors are combined in a synergistic manner, the overall result is increased
resistance to thermal deactivation.

These novel Hb-PAA nanoparticles provide a major

breakthrough in the preparation of bioactive hybrid nanomaterials, which can be sterilized,
without deactivation, for biomedical and bionsensing applications.
Overall, Hb-PAA nanoparticles reported here are highly resistant to deactivation by
steam sterilization, and these are welcome changes for applications in biocatalysis and
biomaterials. These findings are significant because most proteins lose their biological activities
when they are subjected to steam sterilization, while Hb-PAA nanomaterials retained most of
their activity. Additionally, the protein hierarchical structure and activity in nanoparticles is
retained to a large extent. High thermal stability of the hybrid materials, unlike the poor thermal
stability of most proteins, is unique, novel and extremely useful for applications that require
sterile products. These pioneering results might provide a new paradigm for the use of proteinpolymer materials in biosensors, protein therapeutics, tissue engineering scaffolds and implants.
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Chapter 2
A General Approach Towards Ultra-Stable Protein-Polymer
Bioconjugates
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2.1 Abstract
Proteins and enzymes are naturally occuring polymeric biological macromolecules with
well-defined hierarchial structures and highly specific biological activities, however, they are
very sensitive to their environment. Environmental stimuli such as pH, temperature, bacterial
degradation and organic solvents can readily deanture an enzyme1. The limitations of the
enzymes can be overcome when conjuagted to suitable polymers via synthetic approaches2. Here
we report the synthesis of a small library of protein-polymer conjugates using a facile, selfassembled chemical method we have previously published3. Here we have produced proteinpolymer conjugates from covalent linking of low molecular weight poly(acrylic acid) (PAA,
MW 8,000) to various proteins and enzyme under different experimental conditions to form
discrete nanoparticles. The bioconjugates retained significant biological activities when
compared to their unmodified counterparts and showed no nanogel network formation.
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2.2 Introduction
Proteins and enzymes are naturally occuring polymeric biological macromolecules with
well-defined hierarchial structures and highly specific biological activities. Enzymes can
accelerate chemical reactions by orders of magnitude with very high selectivity, under ideal
conditions. However, proteins are generally not suited to function as biomaterials due to their
limitations and sensitivity to environmental stimuli such as pH, temperature, bacterial
degradation and organic solvents1. The limitations of the enzymes can be overcome when
conjuagted to suitable polymers via synthetic approaches2. The combination of proteins and
polymers can lead to new structures and the design of unique biomaterials that can enhance the
properties of both the protein and the polymer for specific applications3. Protein-polymer
conjugates can be synthesized by site-specific conjugation or random conjugation4. Usually this
conjugation is through a covalent link which the functional groups of the polymer are bound to
the surface groups of the protein. Hybrid bioconjugates can potentially be used for applications
in biosensing, biocatalysis or biomedical applications if engineered appropriately5,6.
By wrapping the proteins herein with a soft, hydrophilic, flexible polymer such as the low
molecular weight poly(acrylic acid) (PAA, MW 8000), the stabilities of the proteins can be
improved. Here, the synthesis of a small library of protein-polymer bioconjugates using a
previously developed simple, facile, self-assembled approach is reported7. The data shows that
the method previously developed can be used as a general approach to successfully synthesize
protein-polymer conjugates by covalently linking the carboxyl functional groups of the anionic
polymer to the amine containing lysine amino acids on the protein surface via amide bond
formation through standard carbodiimide chemisrty (Scheme 1).
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Scheme 2.1. The synthesis schematic for the formation of the protein-polymer conjugates by
linking the amino groups of the protein to the carboxyl groups of the polymer, PAA. The
coupling agent used here is 1-ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC).
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Previously it has been shown that conjugation of the proteins with this low molecular
weight PAA (MW 8000) yields highly soluble, discrete nanoparticle formation which is resistant
to steam sterilization7. It has also been shown that random cross-linking of high molecular
weight PAA (MW 450,000) resulted in the formation of soluble nanogel networks. These
nanogels showed streaking and particle precipitation in the wells of the agarose gels8. No
streaking or precipitation was seen previously or shown presently with conjugation to the low
molecular weight PAA. Also, these protein-polymer conjugates have shown significant activity
retention after conjugation when compared to their unmodified counterparts.
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2.3 Experimental
2.3.1 Chemicals and Materials
Glucose Oxidase (GOx) and Lysozyme (Lys) were purchased from Sigma (St.Louis,
MO). Catalase (Cat) was purchased from Worthington Biochemicals (Lakewood, NJ. Protein
solutions were prepared in the respective buffer solutions used for synthesis, as indicated, and the
concentrations were deteremined from the absorbance of each protein using the appropriate
extinction coefficient at 280 nm. The coupling agent used for synthesis, 1-ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC), was purchased from TCI America (Portland, OR).
Poly(acrylic acid) (PAA, 45 wt%, MW 8,000) was purchased from Sigma (St. Louis, MO).

2.3.2 Protein-Polymer Conjugate Synthesis
The protein-polymer conjugates were synthesized by using EDC as the coupling agent
with minor modifications to reported methods9. A mixture of 500 µL of 200 mM Na2HPO4
buffer at pH 6, 7 or 8 with 270 µL of PAA (1 mmol) and 3730 µL of deionized water were added
to a reaction vial, followed by sonication for 5 minutes. Next 100 mmol of EDC was added to the
vial while stirring. The resulting PAA/EDC mixture was stirred for 5 minutes, followed by the
addition of 500 µL of 100 µM protein (50 nmol) and stirred for 12 hours. Specific reaction
conditions for each of the samples are summarized in Table 1. Excess EDC, PAA, and urea byproduct were dialyzed three times with 1000 times the sample volume with 25 kDa molecular
weight cut off dialysis membrane to ensure pure protein-polymer conjugates.
The product obtained from the reaction of PAA (5000 nmol) with GOx (50 nmol) at pH 7
(PAA to GOx mole ratio of 100:1) is designated as GOx-PAA(10)-7, while the reaction of
50,000 nmol PAA with GOx (50 nmol) at pH 7 (PAA to Hb mole ratio of 1000:1) is designated
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as GOx-PAA(1000)-7. This nomenclature will be used throughout the manuscript for unique
identification of specific protein-polymer conjugate samples. Each sample has been centrifuged
at 12,500 rpm and filtered using a 0.22 µm filter to remove invisible precipitates, if any.
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Table 2.1. Reaction conditions for the synthesis of protein-PAA conjugates from Catalase,
Glucose Oxidase or Lysozyme (10 μM, 500 μL, 50 nmol) and EDC (100 mM, 95.8 mg, 500
μmol) in sodium dibasic phosphate buffer, pH 7.

Sample
Protein-PAA(100)
Protein-PAA(500)
Protein-PAA(1000)
Protein-PAA(1500)
Protein-PAA(2000)

[PAA]
(mM)
1
5
10
15
20

PAA Vol
(μL)
135
675
1,350
2,025
2700
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Moles
PAA
5 μmol
25 μmol
50 μmol
75 μmol
100 μmol

Buffer Vol
(μL)
500
500
500
500
500

DI Vol
(μL)
3865
3325
2650
1975
1300

2.3.3 Agarose Gel Electrophoresis
Agarose gels were prepared by dissolving molecular biology grade agarose (0.5% w/v)
(Hoefer Inc., Holliston, MA) in a hot solution of Tris-Acetate (40 mM, pH 7.2). The gels were
run in a horizontal gel electrophoresis apparatus (Gibco Model 200, Life Technologies Inc.,
Grand Island, NY) using Tris-Acetate (40 mM, pH 7.2) as the running buffer. Samples were
loaded into the gel with loading buffer (50 % v/v glycerol and 0.01% m/m bromophenol blue)
and electrophoresis carried out for 30 minutes at 100 V at room temperature. The gel was stained
overnight with 10% v/v acetic acid, 0.02% m/m Coomassie blue and then destained with 10%
v/v acetic acid for an additional night. The gels were photographed using a BioRad Chemidoc
XRS+ (Hercules, CA).

2.3.4 Spectral Measurements
Absorption spectra were recorded on an HP8453 uv-visible spectrophotometer (Agilent
Technologies, Santa Clara, CA). The concentration of protein in solution was determined from
the absorbance using the appropriate extinction coefficient at 280 nm (Table 2). All data was
plotted using Kaleidagraph 4.1.1.
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Table 2.2. Summary of extinction coefficients used for various proteins.
Protein

Extinction Coefficient (M-1 cm-1)

Catalase

420,000

Glucose Oxidase

267,200

Lysozyme

38,940
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2.3.5 Enzymatic Activity Assays
For catalase, the decomposition of hydrogen peroxide (H2O2) was followed from reported
methods10. Catalase (0.5 µM) was added to a solution of H2O2 (20 mM) and the disappearance of
the H2O2 was monitored at 240 nm with respect to time at room temperature.
For glucose oxidase, the activity was determined by a previously reported method11,12. A
solution of glucose (0.2 mM) was added to a mixture of GOx (0.5 µM), HRP (2 µM) and
guaiacol (o-methoxyphenol) (10 mM) in DI water. Oxidation of the substrate, guaiacol, to a
dimeric product (3,3’-dimethoxy-4,4’-biphenoquinone) which has absorption maxima at 470 nm
was monitored as a function of time at room temperature.
For lysozyme, the rate of lysis of Micrococcus lysodeikticus cells is monitored as
reported in the literature13. A suspension of M. Lysodeikticus cells (0.36 mg/mL) was placed in
the spectrophotometer and a blank rate was estrablished by observing the absorbance at 450 nm
with respect to time. Next, a solution of lysozyme (1 µM) was added to the cuvette and the rate
of lysis of the cell walls was established. All enzymatic activity data was plotted using
Kaleidagraph v4.1.1.

2.4 Results and Discussion
Here, the successful synthesis of various protein-polymer conjuagtes using various
proteins with low molecular weight PAA (MW 8,000) is reported. Previously it has been shown
that hemoglobin (Hb) shows activity retention after steam sterilization, using this technology7. It
has also been previously shown that covalent conjugation of Hb to high molecular weight PAA
(MW 450,000) resulted in the formation of nanogels. These nanogels did not show the same
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activity retention after steam sterilization8. Herein the successful synthesis and initial enzymatic
activity studies for the small library produced are reported.

2.4.1 Protein-Polymer Conjugate Synthesis
Proteins are large, polyfunctional, biological macromolecules with a large variety of
surface functional groups, including amines and carboxyl moieties. Previously, the amine groups
of the surface lysine side chains have been modified with a large variety of carboxyl group
containing substrates via standard carbodiimide chemistry14. Using a similar strategy here, a
large excess of PAA (MW 8000, 100 or 1000 molar excess) was covalently attached to the
surface lysine side chains of the proteins using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
as the coupling agent. After synthesis, all of the conjugates produced remained completely
soluble, with no precipitation or nanogel formation. The protein/EDC/PAA reaction mixture was
allowed to react for 12 hours, followed by dialysis with a 25 kDa molecular weight cut off
dialysis membrane to remove any excess PAA, EDC and urea by product.

2.4.2 Agarose Gel Electrophoresis
Covalent attachment of PAA to the proteins is expected to give rise to negatively charged
protein-polymer conjugates like we have shown before7. At pH 7.2, each of these proteins have
different net charges. Amylase, Catalase, and Glucose Oxidase all have net negative charges,
while Lysozyme has a net positive charge. Thusly, conjugation of the PAA to the various
proteins is expected to greatly increase the electrophoretic mobilities of Lysozyme much more
than that of Amylase, Catalase, or Glucose Oxidase.
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As predicted, the Cat-PAA conjugates (100-2,000 fold excess PAA per Catalase) moved
further towards the positive electrode than did the unmodified Catalase sample (Figure 1). This
increase in migration is not due to the physical binding of the PAA to the protein, as no change
in migration between the unmodified Catalase sample and the physical mixture (not shown). The
presence of new bands and the absence of the catalase band in lanes 1-5 indicate the complete
conversion of catalase to the Cat-PAA conjugates. In comparison to previously published low
molecular weight Hb-PAA conjugates7, a similar result has been observed with the conjugation
of catalase with PAA to form Cat-PAA conjugates. In contrast, it has been previously shown that
the nanogel networks formed between the Hb and high molecular weight PAA (MW 450,000)
moved as streaks on the agarose gels under the same electrophoresis conditions8. Thusly, it has
been shown that the technology previously developed with the Hb-PAA conjugates can be
applied to other proteins and enzymes to form the corresponding protein/enzyme-PAA
conjugates.
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Figure 2.1. Agarose gel of Catalase (lane 6), Cat-PAA(100) (lane 5), Cat-PAA(500) (lane 4),
Cat-PAA(1000) (lane 3), Cat-PAA(1500) (lane 2) and Cat-PAA(2000) (lane 1). The conjugates
used here were synthesized at pH 8. All samples were spotted in the center of the gel (0.5%
agarose, 40 mM Tris-Acetate, pH 7.2) and allowed to run for 30 min at 100V. The unmodified
catalase did not migrate far from the center of the gel, towards the positive electrode. The CatPAA conjugates all migrated further towards the positive electrode and do not show any
unreacted catalase in the lanes.
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Conjugates were also prepared with glucose oxidase (100-2,000 fold molar excess PAA)
and saw similar results to those of the catalase conjuagtes mentioned before. The increase in
electrophoretic mobility is again due to the covalent attachment of the PAA. The loss of the band
for unmodified glucose oxidase and the presence of a new band (Figure 2, lanes 2-11) indicate
the complete conversion to the GOx-PAA conjuagtes. This again agrees with our general
approach to synthesize protein-polymer conjugates through a covalent, self-assembled method.

72

Figure 2.2. Agarose gel of GOx (lanes 1 and 12) and GOx-PAA conjuagtes (lanes 2-11). The
unmodified GOx in lanes 1 and 12 show two distinct bands because the protein sample consists
of the monomer and dimer forms of GOx. The conjugates on this gel were synthesized at pH 6
and 7. The lanes consist of GOx-PAA(100) (lane 11, pH 6; lane 10, pH 7), GOx-PAA(500) (lane
9, pH 6; lane 8, pH 7), GOx-PAA(1000) (lane 7, pH 6; lane 6, pH 7), GOx-PAA(1500) (lane 5,
pH 6; lane 4, pH 7) and GOx-PAA(2000) (lane 3, pH 6; lane 2, pH 7). All samples were spotted
in the center of the gel (0.5% agarose, 40 mM Tris-Acetate, pH 7.2) and allowed to run for 30
min at 100 V. The GOx-PAA samples migrated further toward the negative electrode than the
unmodified GOx samples, retaining the two band shape of the unmodified samples, thus there is
no unreacted GOx in the lanes.
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Conjugates prepared from lysozyme and the low molecular weight PAA (100-2,000
molar excess) behaved similarly to the two sets of conjugates previously mentioned. Again,
using our general approach to prepare the protein-polymer conjugates, it is confirmed that the
increase seen in the electrophoretic mobility is due to the covalent conjugation of the PAA to the
lysozyme (Figure 3). Further, there is no indication of free lysozyme in the lane with the
conjugate, indicating the complete conversion of the enzyme to the conjugate form.
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Figure 2.3. Agarose gel of lysozyme (lane 2) and Lys-PAA(100)-7 (lane 1). The unmodified
lysozyme migrated towards the negative electrode, which means that the unmodified lysozyme
has a net positive charge. The Lys-PAA(100) migrated towards the positive electrode and do not
show any unreacted lysozyme in the lane. The samples were spotted in the center of the gel
(0.5% agarose, 40 mM Tris-Acetate, pH 7.2) and allowed to run for 30 min at 100 V.

75

The average pore size of the agarose gels used in Figures 1-3 (0.5% gel) is around 450
nm, and all of the protein-polymer conjugates moved through the gel readily. Thus, it can be
assumed that the conjuagtes are all much smaller than 450 nm in diameter. It can also be
assumed that there is no formation of any nanogel networks, which would have been indicated
by streaks on the gels instead of clearly defined bands8. This is consistent with the observations
of highly soluble conjugates and the low overlap concentration of the PAA15. The agarose gels
confirm the clean and consistent linking of the PAA to the proteins.

2.4.3 Enzymatic Activity Assays
The catalytic activity of catalase was monitored by the decomposition of hydrogen
peroxide (substrate) by its decreasing absorption at 240 nm as a function of time (Figure 4). The
decomposition of H2O2 by catalase (blue curve) and Cat-PAA(1000)-8 (green curve) are almost
identical and PAA by itself did not catalyze the reaction (data not shown). The initial rates of the
conjugate sample were compared to the initial rates of the unmodified catalase and about 12 %
increase in activity of Cat-PAA was observed when compared to the unmodified catalase, but
this increase is within the experimental errors.
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Figure 2.4. The decomposition activity of hydrogen peroxide by catalase (blue curve) and CatPAA(1000)-8 (green curve). All activity data was measured at room temperature in the presence
of 0.5 µM protein and 20 mM H2O2 in 20 mM Na2HPO4, pH 7.2.
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The enzymatic activities of glucose oxidase were also measured by following procedures
reported in literature11,12. The oxidation of a peroxidase substrate to a dimeric product was
monitored at 470 nm as a function of time at room temperature. The activities of the GOx-PAA
conjugates were very similar to that of the unmodified GOx. When comparing the relative
activities, the conjugates showed significant activities, most being close to that of GOx, with the
lowest having 86% activity retention.
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a

b

Figure 2.5. (a) Kinetics traces for GOx (red curve) and GOx-PAA conjugate samples (glucose
(0.2 mM), GOx (0.5 µM), HRP (2 µM) and guaiacol (10 mM) in 20 mM Na2HPO4, pH 7.2). (b)
Comparison of relative activities of the GOx-PAA conjugates with that of the unmodified GOx
at room temperature under the same reaction conditions.
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In order to determine the activities of lysozyme, the rate of lysis of the cell walls of M.
lysodeikticus cells was used. A solution of lysozyme (1 µM) was added to a suspension of M.
lysodeikticus cells (0.36 mg/mL) and the change in absorbance at 450 nm was monitored as a
function of time. The lysozyme was injected after 100 seconds of monitoring the absorbance to
establish a blank rate, if any, and the kinetic traces are compared below in Figure 6. Here a major
difference between the two curves. After the point of lysozyme/Lys-PAA(100)-6 injection (100
sec) the red curve begins to decrease immediately at a steady rate (-6.84 x 10-4 µM-1 s-1), while
the blue curve does not decrease. This is because the cells are too large to gain access to the
lysozyme protein inside of the conjugates. We hypothesize that the pore size of the polymer shell
around the protein is much smaller than the diameter of the M. lysodeikticus cells, thus the cell
wall will not be lysed and no change in absorbance will be observed.
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Figure 2.6. Kinetic traces for Lysozyme (red curve) and Lys-PAA(100)-6 (blue curve). Activity
data was collected in a solution of M. lysodeikticus cells (0.36 mg/mL) and lysozyme (1 µM) in
20 mM Na2HPO4, pH 7.2 at room temperature.
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2.5 Conclusions
Covalent conjugation of polymers with proteins is providing new and exciting
opportunities in biomaterials. However, limited progress has been made in this field due to very
few polymers being used, such as polyethylene glycol, which has a limited number of functional
groups. Previously, a simple, modular, self-assembled approach of covalent conjugation of low
molecular weight PAA (MW 8,000), a multifunctional, hydrophilic polymer to the surface lysine
amino acids of Hb has been reported. These bioconjugates were produced with controlled size,
solubility, improved thermal stabilities and near-reversible denaturation7. Here, the use of the
previously optimized technology to synthesize new, discrete nanoparticles with other various
proteins is reported.
Based on the agarose gel electrophoresis, it can be suggested that discrete nanoparticles
are formed through the covalent conjugation of the low molecular weight PAA (MW 8,000) to
the protein surface lysine groups. Nanogel network formation is not observed because they are
no streaks observed in the agarose gel, nor is there any precipitation in the wells.
Based on the activity data for the conjugates made with catalase and glucose oxidase, the
newly formed conjugates are endowed with the biological activities of their respective
unmodified proteins, showing significant activity retention after conjugation. However, in the
case of the conjugates made with lysozyme the biological activities of the proteins postmodification cannot be determined because the Micrococcus lysodeikticus cells (substrate) are
too large to pass through the pores of the polymer shell.
Overall, previously developed methods were used to create a small library of proteinpolymer conjugates. These are welcome for applications in biocatalysis and biomaterials due to
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the discrete particle formation and significant activity retention. These results currently add to
the idea that one day, protein-polymer biomaterials will be used in biosensors, protein
therapeutics if tailored to the proper conditions.
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